Full Text
The Full Text of this article is available as a PDF (87.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Edwards I. R. Who cares about pharmacovigilance? Eur J Clin Pharmacol. 1997;53(2):83–88. doi: 10.1007/s002280050342. [DOI] [PubMed] [Google Scholar]
- Frost L., Lal S. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. Am J Psychiatry. 1995 May;152(5):810–810. doi: 10.1176/ajp.152.5.810a. [DOI] [PubMed] [Google Scholar]
- Haddad P. Newer antidepressants and the discontinuation syndrome. J Clin Psychiatry. 1997;58 (Suppl 7):17–22. [PubMed] [Google Scholar]
- Lazarou J., Pomeranz B. H., Corey P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200–1205. doi: 10.1001/jama.279.15.1200. [DOI] [PubMed] [Google Scholar]
- Moore T. J., Psaty B. M., Furberg C. D. Time to act on drug safety. JAMA. 1998 May 20;279(19):1571–1573. doi: 10.1001/jama.279.19.1571. [DOI] [PubMed] [Google Scholar]
- Rosenbaum J. F., Zajecka J. Clinical management of antidepressant discontinuation. J Clin Psychiatry. 1997;58 (Suppl 7):37–40. [PubMed] [Google Scholar]
- Schatzberg A. F., Haddad P., Kaplan E. M., Lejoyeux M., Rosenbaum J. F., Young A. H., Zajecka J. Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel. J Clin Psychiatry. 1997;58 (Suppl 7):5–10. [PubMed] [Google Scholar]
- Stahl M. M., Lindquist M., Pettersson M., Edwards I. R., Sanderson J. H., Taylor N. F., Fletcher A. P., Schou J. S. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol. 1997;53(3-4):163–169. doi: 10.1007/s002280050357. [DOI] [PubMed] [Google Scholar]